Overview

Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and compare the bioavailability of fenofibric acid from 2 different dosage strengths of ABT-335.
Phase:
Phase 1
Details
Lead Sponsor:
Abbott
Treatments:
Fenofibrate
Fenofibric acid